Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-01-13 01:43 | 2021-01-08 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP and President-CVS Caremark | Retail-Drug Stores and Proprietary Stores | OPT+S | $75.00 | 25,836 | $1,937,700 | 8,369 | -75.5% |
| 2021-01-13 01:41 | 2021-01-08 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $75.00 | 58,896 | $4,417,200 | 46,008 | -56.1% |
| 2020-11-18 00:22 | 2020-11-13 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP and President-CVS Caremark | Retail-Drug Stores and Proprietary Stores | SALE | $70.00 | 7,138 | $499,660 | 8,023 | -47.1% |
| 2020-11-13 00:16 | 2020-11-10 | CVS | CVS HEALTH Corp | Flum Joshua Matthew | Officer; EVP, ENT STRATEGY & DIGITAL | Retail-Drug Stores and Proprietary Stores | OPT+S | $70.00 | 21,460 | $1,502,200 | 25,001 | -46.2% |
| 2020-05-28 23:56 | 2020-05-26 | CVS | CVS HEALTH Corp | Mayhew Jonathan E. | Officer; EVP - Transformation | Retail-Drug Stores and Proprietary Stores | SALE | $65.00 | 10,556 | $686,140 | 4,732 | -69.0% |
| 2020-05-28 23:49 | 2020-05-26 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | SALE | $65.00 | 270 | $17,550 | 4,547 | -5.6% |
| 2020-05-13 16:08 | 2020-05-11 | CVS | CVS HEALTH Corp | Lotvin Alan | Officer; EVP and President-CVS Caremark | Retail-Drug Stores and Proprietary Stores | BUY | $63.14 | 5,000 | $315,675 | 15,161 | +49.2% |
| 2020-05-01 00:22 | 2020-04-28 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | SALE | $65.00 | 6,234 | $405,210 | 4,817 | -56.4% |
| 2020-04-02 00:14 | 2020-03-30 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $60.00 | 3,030 | $181,800 | 9,760 | -23.7% |
| 2020-01-18 00:31 | 2020-01-15 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $74.79 | 266,476 | $19,929,740 | 437,021 | -37.9% |
| 2020-01-11 01:31 | 2020-01-08 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer; EVP & Chief Operating Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $72.63 | 57,563 | $4,180,801 | 45,045 | -56.1% |
| 2019-11-21 00:27 | 2019-11-18 | CVS | CVS HEALTH Corp | Lynch Karen S | Officer; EVP & Pres, Aetna Bus Unit | Retail-Drug Stores and Proprietary Stores | SALE | $75.00 | 80,143 | $6,010,725 | 41,831 | -65.7% |
| 2019-11-07 00:22 | 2019-11-04 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $68.00 | 23,604 | $1,605,072 | 84,317 | -21.9% |
| 2019-10-02 00:07 | 2019-09-30 | CVS | CVS HEALTH Corp | Flum Joshua Matthew | Officer; EVP, ENT STRATEGY & DIGITAL | Retail-Drug Stores and Proprietary Stores | OPT+S | $63.00 | 17,703 | $1,115,289 | 18,460 | -49.0% |
| 2019-09-14 00:09 | 2019-09-12 | CVS | CVS HEALTH Corp | Boratto Eva C | Officer; EVP & CFO | Retail-Drug Stores and Proprietary Stores | OPT+S | $65.00 | 8,130 | $528,450 | 47,143 | -14.7% |
| 2019-03-11 23:19 | 2019-03-11 | CVS | CVS HEALTH Corp | AGUIRRE FERNANDO | Director | Retail-Drug Stores and Proprietary Stores | BUY | $53.59 | 1,900 | $101,821 | 16,222 | +13.3% |
| 2019-03-11 23:25 | 2019-03-08 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | Retail-Drug Stores and Proprietary Stores | BUY | $52.80 | 2,000 | $105,600 | 7,378 | +37.2% |
| 2019-03-11 23:21 | 2019-03-11 | CVS | CVS HEALTH Corp | BROWN C DAVID II | Director | Retail-Drug Stores and Proprietary Stores | BUY | $53.18 | 10,000 | $531,800 | 111,252 | +9.9% |
| 2019-03-11 23:23 | 2019-03-08 | CVS | CVS HEALTH Corp | DORMAN DAVID W | Director | Retail-Drug Stores and Proprietary Stores | BUY | $52.71 | 9,600 | $506,016 | 122,302 | +8.5% |
| 2019-03-05 00:45 | 2019-03-01 | CVS | CVS HEALTH Corp | AGUIRRE FERNANDO | Director | Retail-Drug Stores and Proprietary Stores | BUY | $58.29 | 3,410 | $198,769 | 14,322 | +31.3% |
| 2019-03-05 00:43 | 2019-03-01 | CVS | CVS HEALTH Corp | LUDWIG EDWARD J | Director | Retail-Drug Stores and Proprietary Stores | BUY | $58.27 | 4,000 | $233,080 | 5,378 | +290.3% |
| 2019-03-02 01:45 | 2019-03-01 | CVS | CVS HEALTH Corp | Clark James David | Officer; SVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $58.14 | 1,664 | $96,745 | 6,893 | -19.4% |
| 2019-02-05 00:10 | 2019-02-01 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer; EVP & Chief Operating Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $64.54 | 77,639 | $5,010,821 | 33,764 | -69.7% |
| 2019-02-05 00:17 | 2019-02-01 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $64.51 | 166,368 | $10,732,400 | 330,209 | -33.5% |
| 2019-01-11 00:26 | 2019-01-08 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $69.04 | 166,368 | $11,486,047 | 330,209 | -33.5% |
| 2018-12-01 00:59 | 2018-11-29 | CVS | CVS HEALTH Corp | Denton David M | Officer; EVP and CFO | Retail-Drug Stores and Proprietary Stores | SALE | $80.13 | 25,159 | $2,015,991 | 403 | -98.4% |
| 2018-11-17 00:19 | 2018-11-14 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | SALE | $82.00 | 14,229 | $1,166,778 | 70,494 | -16.8% |
| 2018-10-03 23:09 | 2018-10-01 | CVS | CVS HEALTH Corp | Boratto Eva C | Officer; EVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.00 | 4,426 | $354,080 | 41,851 | -9.6% |
| 2018-10-03 23:07 | 2018-10-01 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; EVP and Chief HR Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.00 | 21,534 | $1,722,720 | 21,086 | -50.5% |
| 2018-09-19 23:26 | 2018-09-17 | CVS | CVS HEALTH Corp | Boratto Eva C | Officer; EVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $77.16 | 13,311 | $1,027,077 | 41,851 | -24.1% |
| 2018-08-29 23:37 | 2018-08-27 | CVS | CVS HEALTH Corp | Hourican Kevin | Officer; EVP & President, CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $75.00 | 8,564 | $642,300 | 3,571 | -70.6% |
| 2018-05-07 17:17 | 2018-05-04 | CVS | CVS HEALTH Corp | BROWN C DAVID II | Director | Retail-Drug Stores and Proprietary Stores | BUY | $61.99 | 10,000 | $619,900 | 101,252 | +11.0% |
| 2018-05-07 17:20 | 2018-05-04 | CVS | CVS HEALTH Corp | DORMAN DAVID W | Director | Retail-Drug Stores and Proprietary Stores | BUY | $62.22 | 24,300 | $1,511,868 | 104,638 | +30.2% |
| 2018-02-22 00:11 | 2018-02-16 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP & President-CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $71.04 | 19,965 | $1,418,314 | 45,107 | -30.7% |
| 2017-12-23 00:39 | 2017-12-21 | CVS | CVS HEALTH Corp | Bisaccia Lisa | Officer; EVP and Chief HR Officer | Retail-Drug Stores and Proprietary Stores | SALE | $75.00 | 29,445 | $2,208,375 | 15,556 | -65.4% |
| 2017-10-03 23:08 | 2017-10-02 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $81.17 | 20,547 | $1,667,771 | 22,631 | -47.6% |
| 2017-09-19 23:44 | 2017-09-15 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP & President-CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $81.88 | 39,340 | $3,221,159 | 44,997 | -46.6% |
| 2017-09-19 23:42 | 2017-09-18 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer; EVP & Chief Operating Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $83.14 | 85,743 | $7,128,673 | 33,812 | -71.7% |
| 2017-09-15 23:14 | 2017-09-13 | CVS | CVS HEALTH Corp | MERLO LARRY J | Director, Officer; President and CEO | Retail-Drug Stores and Proprietary Stores | OPT+S | $83.07 | 241,150 | $20,032,331 | 299,255 | -44.6% |
| 2017-09-13 00:33 | 2017-09-11 | CVS | CVS HEALTH Corp | Denton David M | Officer; EVP and CFO | Retail-Drug Stores and Proprietary Stores | OPT+S | $79.65 | 237,078 | $18,882,220 | 36,056 | -86.8% |
| 2017-09-13 00:29 | 2017-09-11 | CVS | CVS HEALTH Corp | Moriarty Thomas M | Officer; EVP & General Counsel | Retail-Drug Stores and Proprietary Stores | OPT+S | $79.61 | 90,267 | $7,186,156 | 29,009 | -75.7% |
| 2017-08-18 23:10 | 2017-08-16 | CVS | CVS HEALTH Corp | SWIFT RICHARD J | Director | Retail-Drug Stores and Proprietary Stores | SALE | $79.62 | 2,500 | $199,050 | 3,258 | -43.4% |
| 2017-06-28 23:51 | 2017-06-26 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP, President-CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.00 | 20,333 | $1,626,640 | 44,997 | -31.1% |
| 2017-06-21 23:56 | 2017-06-19 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP, President-CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $76.98 | 20,332 | $1,565,157 | 44,997 | -31.1% |
| 2017-06-13 23:22 | 2017-06-12 | CVS | CVS HEALTH Corp | Denton David M | Officer; EVP and CFO | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.00 | 230,510 | $18,440,800 | 164,563 | -58.3% |
| 2017-03-22 23:20 | 2017-03-21 | CVS | CVS HEALTH Corp | Brennan Troyen A | Officer; EVP and Chief Medical Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $78.73 | 23,849 | $1,877,632 | 70,460 | -25.3% |
| 2017-03-20 23:24 | 2017-03-17 | CVS | CVS HEALTH Corp | Boratto Eva C | Officer; EVP, Cont & Chief Acct Officer | Retail-Drug Stores and Proprietary Stores | OPT+S | $79.60 | 6,029 | $479,908 | 35,585 | -14.5% |
| 2017-03-14 23:21 | 2017-03-13 | CVS | CVS HEALTH Corp | Sussman Andrew | Officer; EVP, Clinical Services | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.40 | 14,104 | $1,133,962 | 8,697 | -61.9% |
| 2017-03-13 23:11 | 2017-03-10 | CVS | CVS HEALTH Corp | Denton David M | Officer; EVP and CFO | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.68 | 95,618 | $7,714,460 | 154,717 | -38.2% |
| 2017-02-18 00:10 | 2017-02-16 | CVS | CVS HEALTH Corp | Roberts Jonathan C | Officer; EVP & President, CVS Caremark | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.00 | 61,196 | $4,895,680 | 28,759 | -68.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.